XTX Topco Ltd Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• XTX Topco Ltd has invested approximately $1.83 million in HCA Healthcare, acquiring 5,295 shares of the company's stock.
• HCA Healthcare reported earnings per share of $6.84 for the last quarter, exceeding analysts' expectations of $6.20, with a revenue of $18.61 billion.
• The company announced a quarterly dividend of $0.72 per share, reflecting an annualized yield of 0.81% and a dividend payout ratio of 12.11%.

XTX Topco Ltd purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 5,295 shares of the company's stock, valued at approximately $1,830,000.

Other institutional investors also recently modified their holdings of the company. Atwood & Palmer Inc. acquired a new stake in shares of HCA Healthcare in the first quarter worth $28,000. Bartlett & CO. Wealth Management LLC boosted its stake in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares in the last quarter. ORG Partners LLC boosted its stake in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after buying an additional 86 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. boosted its stake in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after buying an additional 50 shares in the last quarter. Finally, Legacy Investment Solutions LLC boosted its stake in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after buying an additional 95 shares in the last quarter. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded up $2.85 during trading on Friday, reaching $356.84. The company's stock had a trading volume of 1,369,756 shares, compared to its average volume of 1,559,973. The stock has a market capitalization of $85.84 billion, a P/E ratio of 15.00, a price-to-earnings-growth ratio of 1.11 and a beta of 1.39. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The stock has a 50-day moving average price of $370.66 and a two-hundred day moving average price of $347.13.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The company's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business posted $5.50 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio is 12.11%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on HCA shares. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Robert W. Baird restated a "neutral" rating and issued a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Royal Bank Of Canada set a $401.00 target price on shares of HCA Healthcare and gave the company an "outperform" rating in a research note on Monday. Bank of America downgraded shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price on the stock. in a research note on Wednesday, July 16th. Finally, Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and boosted their target price for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Nine investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and an average price target of $396.46.

Insider Activity at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer directly owned 12,646 shares of the company's stock, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.